A Clinical Grade Sequencing-Based Assay for CEBPA Mutation Testing

Slides:



Advertisements
Similar presentations
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Advertisements

Keyur P. Patel, Bedia A. Barkoh, Zhao Chen, Deqin Ma, Neelima Reddy, L
Detection of Exon 12 Mutations in the JAK2 Gene
Performance Evaluation of the TheraTyper-GJB2 Assay for Detection of GJB2 Gene Mutations  Ji-Yong Chun, Soo-Kyung Shin, Kyung Tae Min, Woojae Cho, Jaeil.
High-Throughput Homogeneous Mass Cleave Assay Technology for the Diagnosis of Autosomal Recessive Parkinson's Disease  Christopher Schroeder, Michael.
Todd S. Laughlin, Michael W. Becker, Jane L. Liesveld, Deborah A
Impact of Mutation Type and Amplicon Characteristics on Genetic Diversity Measures Generated Using a High-Resolution Melting Diversity Assay  Matthew.
High-Throughput, Multiplex Genotyping Directly from Blood or Dried Blood Spot without DNA Extraction for the Screening of Multiple G6PD Gene Variants.
Suppression of Wild-Type Amplification by Selectivity Enhancing Agents in PCR Assays that Utilize SuperSelective Primers for the Detection of Rare Somatic.
A Novel Mutation and Large Size Polymorphism Affecting the V2 Domain of Keratin 1 in an African-American Family with Severe, Diffuse Palmoplantar Keratoderma.
Mutation Spectrum of the Survival of Motor Neuron 1 and Functional Analysis of Variants in Chinese Spinal Muscular Atrophy  Yu-jin Qu, Jin-li Bai, Yan-yan.
Betaine, Dimethyl Sulfoxide, and 7-Deaza-dGTP, a Powerful Mixture for Amplification of GC-Rich DNA Sequences  Marco Musso, Renata Bocciardi, Sara Parodi,
Annotation of Sequence Variants in Cancer Samples
Philippe Szankasi, Mohamed Jama, David W. Bahler 
A Novel Targeted Approach for Noninvasive Detection of Paternally Inherited Mutations in Maternal Plasma  Jessica M.E. van den Oever, Ivonne J.H.M. van.
Annotation of Sequence Variants in Cancer Samples
Clinical Relevance of Sensitive and Quantitative STAT3 Mutation Analysis Using Next- Generation Sequencing in T-Cell Large Granular Lymphocytic Leukemia 
Performance Evaluation of Two Methods Using Commercially Available Reagents for PCR-Based Detection of FMR1 Mutation  Jane S. Juusola, Paula Anderson,
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples  Prashanth Setty, Jennifer Hammes, Thomas Rothämel, Valentina.
Hou-Sung Jung, Gregory J. Tsongalis, Joel A. Lefferts 
DNA Diagnostics by Surface-Bound Melt-Curve Reactions
Ken B. Waites, Li Xiao, Vanya Paralanov, Rose M. Viscardi, John I
Detection of KRAS and BRAF Mutations in Colorectal Carcinoma
Detection of an Apparent Homozygous 3120G>A Cystic Fibrosis Mutation on a Routine Carrier Screen  Denise LaMarche Heaney, Patrick Flume, Lauren Hamilton,
Performance Evaluation of the TheraTyper-GJB2 Assay for Detection of GJB2 Gene Mutations  Ji-Yong Chun, Soo-Kyung Shin, Kyung Tae Min, Woojae Cho, Jaeil.
Toward a Survey of Somatic Mutation of the NF1 Gene in Benign Neurofibromas of Patients with Neurofibromatosis Type 1  Ingrid Eisenbarth, Kim Beyer, Winfrid.
Andrea Gaedigk, Amanda K. Riffel, J. Steven Leeder 
Low Copy Number DNA Template Can Render Polymerase Chain Reaction Error Prone in a Sequence-Dependent Manner  Mansour Akbari, Marianne Doré Hansen, Jostein.
Volume 54, Issue 3, Pages (September 1998)
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Reliable and Sensitive Detection of Fragile X (Expanded) Alleles in Clinical Prenatal DNA Samples with a Fast Turnaround Time  Sara Seneca, Willy Lissens,
Detection of Exon 12 Mutations in the JAK2 Gene
Markus Rechsteiner, Adriana von Teichman, Jan H
Comprehensive Diagnostic Testing for Stereocilin
Catherine E. Keegan, Anthony A. Killeen 
Analysis of Rare APC Variants at the mRNA Level
Keyur P. Patel, Bedia A. Barkoh, Zhao Chen, Deqin Ma, Neelima Reddy, L
The c.1364C>A (p.A455E) Mutation in the CFTR Pseudogene Results in an Incorrectly Assigned Carrier Status by a Commonly Used Screening Platform  Kristin.
Size Polymorphisms in the Human Ultrahigh Sulfur Hair Keratin-Associated Protein 4, KAP4, Gene Family  Naoyuki Kariya, Yutaka Shimomura, Masaaki Ito 
Supplemental Figure 3 A B C T-DNA 1 2 RGLG1 2329bp 3 T-DNA 1 2 RGLG2
Splice Site and Deletion Mutations in Keratin (KRT1 and KRT10) Genes: Unusual Phenotypic Alterations in Scandinavian Patients with Epidermolytic Hyperkeratosis 
The Molecular Pathology of Primary Immunodeficiencies
Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell–Free DNA from Patients with Advanced Non–Small Cell.
A Multi-Exonic BRCA1 Deletion Identified in Multiple Families through Single Nucleotide Polymorphism Haplotype Pair Analysis and Gene Amplification with.
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
A Presenilin-1 Truncating Mutation Is Present in Two Cases with Autopsy-Confirmed Early-Onset Alzheimer Disease  Carolyn Tysoe, Joanne Whittaker, John.
Application of COLD-PCR for Improved Detection of NF2 Mosaic Mutations
Evaluating the Effect of Unclassified Variants Identified in MMR Genes Using Phenotypic Features, Bioinformatics Prediction, and RNA Assays  Lucia Pérez-Cabornero,
Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation Analysis  Marla Lay, Rajan Mariappan, Jason Gotlib, Lisa Dietz, Siby Sebastian,
Long-Range Polymerase Chain Reaction for Specific Full-Length Amplification of the Human Keratin 14 Gene and Novel Keratin 14 Mutations in Epidermolysis.
Genomic Technologies and the New Era of Genomic Medicine
Human Elastase 1: Evidence for Expression in the Skin and the Identification of a Frequent Frameshift Polymorphism  Ulvi Talas, John Dunlop, Sahera Khalaf,
Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic.
Ming-Tseh Lin, Li-Hui Tseng, Roy G. Rich, Michael J
Strategy for Robust Detection of Insertions, Deletions, and Point Mutations in CEBPA, a GC-Rich Content Gene, Using 454 Next-Generation Deep-Sequencing.
Danielle C. Smith, Alina Esterhuizen, Jacquie Greenberg 
A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing  Liying Zhang, Tomas Kirchhoff, Cindy.
A Real-Time PCR Assay for the Simultaneous Detection of Functional N284I and L412F Polymorphisms in the Human Toll-Like Receptor 3 Gene  Robert A. Brown,
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer  Zengliu Su, Dora Dias-Santagata,
Novel Method for PIK3CA Mutation Analysis
Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung Adenocarcinomas  Qiulu Pan, William Pao, Marc.
Improved Detection of KIT Exon 11 Duplications in Formalin-Fixed, Paraffin-Embedded Gastrointestinal Stromal Tumors  Jerzy Lasota, Bartosz Wasag, Sonja.
A Novel and Rapid Method of Determining the Effect of Unclassified MLH1 Genetic Variants on Differential Allelic Expression  Sheron Perera, Brian Li,
Relationship between CFTR and CTRC Variants and the Clinical Phenotype in Late- Onset Cystic Fibrosis Disease with Chronic Pancreatitis  Anna C. Tomaiuolo,
Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF  Alois H. Lang, Heinz Drexel, Simone Geller-Rhomberg,
A Mutation in the V1 Domain of K16 is Responsible for Unilateral Palmoplantar Verrucous Nevus  Alessandro Terrinoni, Vincenzo De Laurenzi, Eleonora Candi,
Anthony M. Raizis, Martin M. Ferguson, David T. Nicholls, Derek W
Exon Skipping in IVD RNA Processing in Isovaleric Acidemia Caused by Point Mutations in the Coding Region of the IVD Gene  Jerry Vockley, Peter K. Rogan,
Fang Wang, Yunfeng Wang, Jie Ding, Jiyun Yang  Kidney International 
Presentation transcript:

A Clinical Grade Sequencing-Based Assay for CEBPA Mutation Testing Amir Behdad, Helmut C. Weigelin, Kojo S.J. Elenitoba-Johnson, Bryan L. Betz  The Journal of Molecular Diagnostics  Volume 17, Issue 1, Pages 76-84 (January 2015) DOI: 10.1016/j.jmoldx.2014.09.007 Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 Assay design and optimization. A: CEBPA is a single-exon gene with a 1077-bp coding region. Primers were designed such that two overlapping fragments spanning the entire coding region are amplified by PCR. B: Optimization of the PCR required the addition of 8% dimethyl sulfoxide (DMSO) and the use of GC-rich PCR buffer. Primer design and optimization of the PCR/sequencing reactions was challenging because of the high GC content of the coding region (75%), the presence of a trinucleotide repeat (GCC)7, and problems with secondary structure. C: Amplification products after optimization. D: Sensitivity of direct sequencing for CEBPA mutations. Mutation-positive genomic DNA was diluted into wild-type DNA. Mutations could be identified reliably down to a level of 10%. DBD/ZIP, DNA binding and dimerization domain; TAD1, transactivation domain 1; TAD2, transactivation domain 2; WT, wild type. The Journal of Molecular Diagnostics 2015 17, 76-84DOI: (10.1016/j.jmoldx.2014.09.007) Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 Sequence traces of N- and C-terminal CEBPA mutations, variants of unknown significance, and the c.584_589dup, p.H195_P196dup polymorphism. A variety of sequence alterations were detected, including both length-affecting mutations and nucleotide substitution mutations. The wild-type CEBPA sequence is listed above the traces. The insertion mutation in the second panel of the left column (c.245_246insGG, p.F82fs) showed more than 90% mutant allele frequency and therefore was interpreted as homozygous. Brackets in each panel indicate the deleted/inserted/duplicated nucleotide sequence; asterisks, nucleotide substitutions. The Journal of Molecular Diagnostics 2015 17, 76-84DOI: (10.1016/j.jmoldx.2014.09.007) Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 3 Distribution of CEBPA mutations and variants identified in this study. The locations of the mutations are shown with respect to the CEBPA protein and functional regions. Arrows depict the two translation initiation sites at amino acids (aa) 1 and 120. For interpretative purposes, the coding region of CEBPA was divided into three regions: N-terminal (aa 1 to 120), midregion (aa 121 to 277), and C-terminal (aa 278 to 358). The majority of CEBPAdm cases harbor a combination of a truncating frameshift or nonsense mutation in the N-terminal region and an inframe insertion/deletion or missense mutation in the C-terminal region. Mutations in CEBPAsm cases are distributed in the entire coding region, with a greater portion in the midregion. Missense and inframe mutations of the N-terminal and midregions were classified as variants of unknown significance. TAD1, transactivation domain 1 (aa 70 to 97); TAD2, transactivation domain 2 (aa 127 to 200); DBD/ZIP, DNA binding and dimerization domain (aa 278 to 358). The Journal of Molecular Diagnostics 2015 17, 76-84DOI: (10.1016/j.jmoldx.2014.09.007) Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 4 Examples of CEBPAdm cases with equal (case 41) and discrepant (case 79) mutant allele frequencies. Brackets highlight the deleted/duplicated sequence; asterisks, the mutant peak. The Journal of Molecular Diagnostics 2015 17, 76-84DOI: (10.1016/j.jmoldx.2014.09.007) Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions